Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
National Cancer Institute (NCI)
Conjupro Biotherapeutics, Inc.
Xencor, Inc.
Filamon LTD
AstraZeneca
Atavistik Bio, Inc
Seagen Inc.
Dana-Farber Cancer Institute
PMV Pharmaceuticals, Inc
AstraZeneca
The Methodist Hospital Research Institute
University of Michigan Rogel Cancer Center
Alterome Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Rutgers, The State University of New Jersey
BeOne Medicines
Aveni Foundation
Bayer
ViroMissile, Inc.
Arcus Biosciences, Inc.
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Genmab
Jazz Pharmaceuticals
Kaiser Permanente
Children's Oncology Group
AstraZeneca
Pfizer
Duke University
AstraZeneca
Tizona Therapeutics, Inc
University of Florida
Essen Biotech
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
A2 Biotherapeutics Inc.
Clasp Therapeutics, Inc.
BioNTech SE
Eli Lilly and Company
Poseida Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
National Cancer Institute (NCI)